One unsettling finding to emerge from the FDA hearings is how often breast jobs have to be redone. The McGhan study showed that more than one out of five women with cosmetically enhanced busts–and 39 percent of cancer patients–need additional surgery within three years. The top reasons for such procedures include replacement of ruptured and leaking implants and alleviation of hardened breasts caused by capsular contracture and other factors. read more